SCHEMBL4907012

SCHEMBL4907012

CCN(c1ccc(OCc2cccc(F)c2F)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ESR1 P03372 3/20 0.40
TSHR P16473 2/20 0.40
KEAP1 Q14145 2/20 0.38
NFE2L2 Q16236 2/20 0.38
MRGPRX4 Q96LA9 3/20 0.38
ATM Q13315 1/20 0.38
NSD2 O96028 1/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
RECQL P46063 1/20 0.37
ESR2 Q92731 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK1 P28482 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895665 0.91 LMNA (0.41) LMNAALDH1A1ESR1TSHRKEAP1
SCHEMBL4905972 0.90 LMNA (0.55) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4894515 0.89 LMNA (0.45) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4904151 0.87 LMNA (0.56) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4907053 0.86 LMNA (0.48) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4906496 0.84 LMNA (0.51) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4906732 0.83 LMNA (0.47) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4897627 0.83 KEAP1 (0.48) LMNAHSD17B10TSHRKEAP1NFE2L2
SCHEMBL4906315 0.83 LMNA (0.46) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4897505 0.81 LMNA (0.54) LMNAHSD17B10ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885HSD17B10 434/4885ALDH1A1 2664/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885HSD17B10 434/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885HSD17B10 434/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.